KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Current Assets (2018 - 2025)

Historic Current Assets for Aurinia Pharmaceuticals (AUPH) over the last 10 years, with Q3 2025 value amounting to $438.7 million.

  • Aurinia Pharmaceuticals' Current Assets fell 39.1% to $438.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $438.7 million, marking a year-over-year decrease of 39.1%. This contributed to the annual value of $446.6 million for FY2024, which is 513.09% up from last year.
  • As of Q3 2025, Aurinia Pharmaceuticals' Current Assets stood at $438.7 million, which was down 39.1% from $409.0 million recorded in Q2 2025.
  • In the past 5 years, Aurinia Pharmaceuticals' Current Assets registered a high of $513.3 million during Q4 2021, and its lowest value of $329.2 million during Q3 2021.
  • Its 5-year average for Current Assets is $423.0 million, with a median of $424.8 million in 2023.
  • In the last 5 years, Aurinia Pharmaceuticals' Current Assets crashed by 2002.26% in 2021 and then skyrocketed by 3963.41% in 2022.
  • Over the past 5 years, Aurinia Pharmaceuticals' Current Assets (Quarter) stood at $513.3 million in 2021, then decreased by 13.79% to $442.5 million in 2022, then dropped by 4.01% to $424.8 million in 2023, then rose by 5.13% to $446.6 million in 2024, then fell by 1.76% to $438.7 million in 2025.
  • Its Current Assets was $438.7 million in Q3 2025, compared to $409.0 million in Q2 2025 and $405.8 million in Q1 2025.